Global law firm White & Case LLP has advised Bpifrance, a reference shareholder in the SEQENS Group (SEQENS) since 2021, on the Group’s financial restructuring.
Upon completion of the contemplated restructuring, the Group’s senior lenders will become the new shareholders of SEQENS, reinforcing their long-term commitment to the Group’s future development.
Bpifrance will remain involved as a Group partner in its capacity as shareholder, lender and member of the board of directors.
Final implementation of the restructuring is expected in December 2026.
SEQENS is a world leader in the development and production of active pharmaceutical ingredients, intermediates and specialty ingredients.
The White & Case team in Paris that advised on the transaction was led by partners Anne-Sophie Noury and Saam Golshani, and included partners Samir Berlat, Quirec de Kersauson and Orion Berg; counsel Kevin Boyero and Sarah Kouchad; and associates Simon Martin-Gousset, Ibtissame Sefraoui, Aliénor Huchot, Salomé Lecroc, Victor Menu, Rafael Galvez and Louis Roussier.
Press contact
For more information please speak to your local media contact.
